AmSurg Corp., which operates outpatient surgery centers, said Tuesday its board of directors approved a $25 million stock buyback program in a move to mitigate the dilutive effect of shares issued with the company's stock incentive plan.
The company plans on buying back the stock over the next 12 months. As of June 30, AmSurg had 31.5 million shares of common stock outstanding.
Shares of AmSurg fell 76 cents, or 2.9 percent, to close at $25.47. The stock has traded between $21.96 and $29.76 over the last 52 weeks.
The company plans on buying back the stock over the next 12 months. As of June 30, AmSurg had 31.5 million shares of common stock outstanding.
Shares of AmSurg fell 76 cents, or 2.9 percent, to close at $25.47. The stock has traded between $21.96 and $29.76 over the last 52 weeks.
0 comments:
Post a Comment